The current curative approaches for ischemia/reperfusion injury on liver transplantation are still under debate for their safety and efficacy in patients with end-stage liver disease. We present the SIMVA statin donor treatment before Liver Transplants study.
Donor Simvastatin Treatment Is Safe and Might Improve Outcomes After Liver Transplantation: A Randomized Clinical Trial
Ekser, Burcin;Barbara, Marco;Luca, Angelo;Gruttadauria, Salvatore
2022-01-01
Abstract
The current curative approaches for ischemia/reperfusion injury on liver transplantation are still under debate for their safety and efficacy in patients with end-stage liver disease. We present the SIMVA statin donor treatment before Liver Transplants study.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Donor_Simvastatin_Treatment_Is_Safe_and_Might.100 (1).pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Dimensione
735.41 kB
Formato
Adobe PDF
|
735.41 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
